The European Medicines Agency Facilitates Access to Medicines in Low- And Middle-Income Countries

Expert Review of Clinical Pharmacology - United Kingdom
doi 10.1080/17512433.2020.1724782
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

What Is the European Medicines Agency?

Epidemiology and Psychiatric Sciences
Mental HealthEpidemiologyPublic HealthEnvironmentalPsychiatryOccupational Health
2012English

Access to Medicines and European Market Integration

SSRN Electronic Journal
2016English

FDA Reform and the European Medicines Evaluation Agency

Harvard Law Review
Law
1995English

Improved Drug Access in Low and Middle-Income Countries

The Lancet Oncology
Oncology
2016English

P1-159 Income and Access to Medicines in Brazil, 2008-2009

Journal of Epidemiology and Community Health
EpidemiologyPublic HealthOccupational HealthEnvironmental
2011English

European Medicines Agency Workshop on Biosimilar Monoclonal Antibodies

mAbs
AllergyImmunology
2009English

How Can Pricing and Reimbursement Policies Improve Affordable Access to Medicines? Lessons Learned From European Countries

Applied Health Economics and Health Policy
MedicineHealth PolicyEconomicsEconometrics
2017English

Erratum To: Access to Controlled Medicines for Anesthesia and Surgical Care in Low-Income Countries: A Narrative Review of International Drug Control Systems and Policies

Canadian Journal of Anaesthesia
MedicineAnesthesiologyPain Medicine
2017English

Improving Risk Assessment in the European Food Safety Authority: Lessons From the European Medicines Agency

Frontiers in Plant Science
Plant Science
2020English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2025 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy